Tags |
|
|
Links |
|
|
Top Articles - Showing Up Late to the Party Part 1
I'm going to reiterate something I stated to a new investor we met this
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
weekend: if you show up late to a party, the best food is likely to be
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
mostly gone, and you get the crumbs or something you didn't want. I was
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
illustrating a point about real estate throughout the country.
It's a
It's a
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ommon affliction of Californians in particular that is understandable.
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
his is a terribly popular state that experienced price increases faster
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
than a waistline in the first year of marriage. Real estate here is a n
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
o-brainer, IF you bought early enough or smart enough.
Don't agree? He
Don't agree? He
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
e's the test: go out and ask a handful of people if they would buy CA r
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
al estate today. Then ask them if they would have bought it twenty year
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ago if they could, had they known what prices were going to do. Anyone
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
who says no to the second question is either an idiot, a liar, or has s
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
me chip on their shoulder against making money or owning property.
How
How
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ver, CA does not have a monopoly on drastic price increases. It's happe
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ned in many parts of the United States. The rest of the country did not
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
sit in cold storage, frozen at the costs of yesteryear while CA was see
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ng double digit appreciation. Many other places went up, too. And, like
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
CA, the best time to get there was a long time ago. That's how apprecia
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ion works. How you feel about it depends on which side of it you're on:
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
having bought or not.
See part 2 of this series for the continuation..
See part 2 of this series for the continuation..
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/139644/toparticles-Showing-Up-Late-to-the-Party-Part-1.html">Showing Up Late to the Party Part 1</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/139644/toparticles-Showing-Up-Late-to-the-Party-Part-1.html]Showing Up Late to the Party Part 1[/url]
Related Articles:
How To Get Free Website Traffic
What's the Fuzz about E-currency Trading
Bookmark it:
|